En Carta Diagnostics
French tech company | Builders Republic
About
Deeptech maker of rapid point-of-care molecular diagnostic kits that helps clinicians detect disease on the spot — a frugal single-use cassette using aptamers to flag pathogens, with early Lyme disease as its first test, designed for fast results outside the lab.
Key facts
- Status
- Active
- Sectors
- Healthcare & Life Sciences
- Latest stage
- Seed
- Founded
- 2022
- City
- MALAKOFF
- Region
- IDF
- Tracked rounds
- 1
- Amount raised
- 1.0 M€ raised since 2020
Funding rounds
- Seed — 2024